Overview
This lecture focused on pain, nociception (the perception of pain), the neural mechanisms behind it, and how acute pain can become chronic. Key topics included pain pathways, neurotransmitters, chronic pain mechanisms, and the pharmacology of pain relief.
Pain and Nociception
- Pain serves as a warning system to signal danger or injury for self-preservation.
- Nociceptors are specialized pain nerves, comprising mainly A-delta and C fibers.
- Not all afferent nerves transmit pain; only those classified as nociceptors do.
Congenital Insensitivity to Pain (CIPA)
- CIPA is caused by mutations in the TrkA receptor or nerve growth factor (NGF) gene.
- NGF binding to TrkA is required for sensory and autonomic neuron survival.
- CIPA results in inability to feel pain or temperature changes and lack of sweat.
Pain Pathways and Neurotransmitters
- Afferent neurons carry sensory info (including pain) to the dorsal root of the spinal cord.
- Common injury mediators: ATP, bradykinin, prostaglandins, hydrogen ions, heat, and pressure can all activate nociceptors.
- Substance P and CGRP are released by pain nerves and contribute to inflammation and pain.
Types of Pain Fibers
- A-delta fibers: myelinated, transmit sharp, localized pain quickly.
- C fibers: unmyelinated, transmit dull, diffuse, slower pain.
- A-alpha and A-beta fibers: thickly myelinated, conduct touch and pressure, not pain, but can modulate pain signals.
Receptors and Pharmacological Modulation
- Ionotropic glutamate receptors (AMPA: sodium; NMDA: sodium and calcium) depolarize nerves and play roles in pain plasticity.
- Metabotropic glutamate receptors act via second messengers (PKA pathway) and modulate nerve sensitivity.
- Cannabinoid and opioid receptors inhibit pain through similar signaling cascades (inhibiting adenylyl cyclase and PKA).
- Prostaglandins activate pain and inflammation; NSAIDs inhibit cyclooxygenase (COX) to reduce prostaglandin synthesis.
- Steroidal anti-inflammatories (e.g., cortisone) inhibit phospholipase A2, blocking arachidonic acid release and prostaglandin formation.
Chronic Pain and Sensitization
- Chronic pain results from dysregulation of substance P, CGRP, and increased PKA signaling.
- Central sensitization: heightened excitability in CNS pain pathways leads to amplified pain.
- Hyperalgesia: exaggerated response to painful stimuli.
- Allodynia: pain from typically non-painful stimuli.
- Silent nociceptors can become active and contribute to chronic pain after injury.
Neuromuscular Junction Disorders
- Myasthenia gravis: autoimmune destruction of nicotinic acetylcholine receptors causes muscle weakness.
- Nerve agents (e.g., sarin gas): inhibit acetylcholinesterase, preventing breakdown of acetylcholine.
- Anticholinergic drugs: block acetylcholine receptors.
- Botox (botulinum toxin): prevents acetylcholine release from motor nerves.
Key Terms & Definitions
- Nociceptor — A nerve cell that detects painful stimuli.
- CIPA — Congenital insensitivity to pain with anhidrosis, a genetic disorder eliminating pain/heat sensation and sweating.
- Substance P/CGRP — Neurotransmitters involved in pain and inflammation.
- Ionotropic receptor — A receptor that directly allows ion flow to depolarize neurons (e.g., AMPA, NMDA).
- Metabotropic receptor — G-protein coupled receptor activating intracellular signaling cascades.
- Hyperalgesia — Increased sensitivity to painful stimuli.
- Allodynia — Pain resulting from non-painful stimuli.
- Central sensitization — Increased responsiveness of CNS to pain signals.
- NSAIDs — Nonsteroidal anti-inflammatory drugs that inhibit prostaglandin synthesis.
- Botox — Botulinum toxin that blocks acetylcholine release at neuromuscular junctions.
Action Items / Next Steps
- Review the mechanisms of nociceptor activation and neurotransmitters involved.
- Study differences between ionotropic and metabotropic receptors, and their roles in pain signaling.
- Understand the pharmacological strategies for pain/inflammation (NSAIDs, steroids, opioids, cannabinoids).
- Review types of nerve fibers and their conduction properties.
- Prepare for review questions on pain pathways, chronic pain mechanisms, and key receptor functions.